Lv23
150 积分 2025-08-06 加入
Bispecific Antibody Targeting Both IL33 and TSLP for Asthma and COPD
2天前
已关闭
Bispecific Antibody Targeting Both IL33 and TSLP for Asthma and COPD
2天前
已关闭
Bispecific Antibody Targeting Both IL33 and TSLP for Asthma and COPD
2天前
已关闭
Development and Challenges of Cyclic Peptides for Immunomodulation
19天前
已完结
The coming of age of cyclic peptide drugs: an update on discovery technologies
19天前
已完结
A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma
22天前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
24天前
已完结
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
1个月前
已完结
Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo
1个月前
已完结
皖公网安备34019202002308
